Case Study: Clal Biotechnology Industries achieves automated, centralized regulatory compliance and reduced costs with ProcessGene GRC Software Suite

Clal Biotechnology Industries - Customer Case Study

Clal Biotechnology Industries (CBI) is a life‑sciences investment group managing over $600 million in capital. As a holding company with high‑technology investments, CBI faced significant GRC challenges—most critically the need to control and monitor risks tied to the accuracy of financial reporting and ensure consistent corporate governance and regulatory compliance across its portfolio.

CBI implemented the ProcessGene GRC Software Suite for regulatory compliance, corporate governance, automated policy enforcement, IT‑GRC and risk management. The solution centralized control and reporting, automated control execution and audits, preserved objective evidence of compliance, and established ongoing compliance and risk‑mitigation frameworks—reducing manual effort, lowering costs, and delivering more consistent, quantifiable IT‑GRC and risk‑management results.

Clal Biotechnology Industries